Sun Pharmaceutical Industries Ltd (SUN.NS)
17 Oct 2018
To access the newsletter, click on the link: http://share.thomsonreuters.com/assets/newsletters/Indiamorning/MNC_IN_08162018.pdf If you would like to receive this newsletter via email, please register at: https://forms.thomsonreuters.com/india-morning/ FACTORS TO WATCH 11:30 am: Banking Secretary Rajiv Kumar at launch of Canara Bank’s digital branch in New Delhi. LIVECHAT - BONDS UPDATE Reuters interest rate reporter Dhara Ranasinghe delves into gove
* Stock top gainer on NSE index (Adds details on U.S. and India sales, share movement)
Aug 14 India's largest drugmaker Sun Pharmaceutical Industries Ltd posted a first-quarter profit on Tuesday, beating street estimates.
MUMBAI, June 12 India's largest drugmaker Sun Pharmaceutical Industries Ltd said on Tuesday the U.S. Food and Drug Administration (FDA) cleared its Halol drug plant, which had been under supply restrictions due to quality control failures.
* NSE index ended 0.01 pct down, BSE index closed 0.05 pct lower
May 28 Indian shares ended higher for a third session on Monday, as lower crude prices and a firmer rupee lifted sentiment, with financial and oil stocks accounting for much of the gains.
May 28 Indian equities gained for a third straight session on Monday as a sharp drop in crude prices and a recovery in the rupee boosted sentiment, while shares of Sun Pharmaceutical Industries saw their best day in over three years on strong fourth-quarter results.
* Plans to reduce "unviable" generics research (Adds managing director comments from conference call)
May 25 Sun Pharmaceutical Industries Ltd , India's largest drugmaker, posted fourth-quarter net profit way above expectations.